Nefazodone
- TRADE NAME: Serzone (Bristol-Myers Squibb)
- INDICATIONS: Depression
- CLASS: Antidepressant, CYP3A4 inhibitor, Norepinephrine reuptake inhibitor
- HALF-LIFE: 2–4 hours
Abiraterone, Aprepitant, Astemizole, Atorvastatin, Avanafil, Buspirone, Cabozantinib, Calcifediol, Ceritinib, Copanlisib, Crizotinib, Darunavir, Dasatinib, Dronedarone, Eletriptan, Erlotinib, Eszopiclone, Fesoterodine, Flibanserin, Fluticasone Propionate, Indinavir, Isocarboxazid, Ivabradine, Ixabepilone, Lapatinib, Lomitapide, Lumateperone, MAO inhibitors, Methylergonovine, Midostaurin, Mifepristone, Neratinib, Olaparib, Osimertinib, Paclitaxel, Palbociclib, Phenelzine, Pimozide, Ponatinib, Rimonabant, Romidepsin, Ruxolitinib, Selegiline, Sibutramine, Simvastatin, Solifenacin, Sonidegib, St John's Wort, Sumatriptan, Sunitinib, Temsirolimus, Ticagrelor, Tipranavir, Tolvaptan, Tramadol, Tranylcypromine, Trazodone, Ulipristal, Vemurafenib, Vorapaxar
PREGNANCY CATEGORY: C
SUICIDALITY AND ANTIDEPRESSANT DRUGS and HEPATOTOXICITY
See full prescribing information for complete boxed warning.
Please login to see the rest of this drug profile
Page last updated 08/01/2022
Symbol key
Incidence 
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Seriousness
- Hospitalization possible
- Life threatening
- Fatal
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric
